These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 24368564)
1. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Meylan F; Hawley ET; Barron L; Barlow JL; Penumetcha P; Pelletier M; Sciumè G; Richard AC; Hayes ET; Gomez-Rodriguez J; Chen X; Paul WE; Wynn TA; McKenzie AN; Siegel RM Mucosal Immunol; 2014 Jul; 7(4):958-68. PubMed ID: 24368564 [TBL] [Abstract][Full Text] [Related]
2. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692 [TBL] [Abstract][Full Text] [Related]
3. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Meylan F; Richard AC; Siegel RM Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439 [TBL] [Abstract][Full Text] [Related]
4. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity. Valatas V; Kolios G; Bamias G Front Immunol; 2019; 10():583. PubMed ID: 30972074 [TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation. Siakavellas SI; Bamias G Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067 [TBL] [Abstract][Full Text] [Related]
7. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443 [TBL] [Abstract][Full Text] [Related]
8. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. Ferdinand JR; Richard AC; Meylan F; Al-Shamkhani A; Siegel RM J Immunol; 2018 Feb; 200(4):1360-1369. PubMed ID: 29335258 [TBL] [Abstract][Full Text] [Related]
10. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Yu X; Pappu R; Ramirez-Carrozzi V; Ota N; Caplazi P; Zhang J; Yan D; Xu M; Lee WP; Grogan JL Mucosal Immunol; 2014 May; 7(3):730-40. PubMed ID: 24220298 [TBL] [Abstract][Full Text] [Related]
11. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality. Holmkvist P; Roepstorff K; Uronen-Hansson H; Sandén C; Gudjonsson S; Patschan O; Grip O; Marsal J; Schmidtchen A; Hornum L; Erjefält JS; Håkansson K; Agace WW Mucosal Immunol; 2015 May; 8(3):545-58. PubMed ID: 25269704 [TBL] [Abstract][Full Text] [Related]
12. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma. Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596 [No Abstract] [Full Text] [Related]
13. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698 [TBL] [Abstract][Full Text] [Related]
14. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728 [TBL] [Abstract][Full Text] [Related]
15. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771 [TBL] [Abstract][Full Text] [Related]
16. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells. Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176 [TBL] [Abstract][Full Text] [Related]
17. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients. Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972 [TBL] [Abstract][Full Text] [Related]
18. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo. Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818 [TBL] [Abstract][Full Text] [Related]
19. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. Jones GW; Stumhofer JS; Foster T; Twohig JP; Hertzog P; Topley N; Williams AS; Hunter CA; Jenkins BJ; Wang EC; Jones SA FASEB J; 2011 Jan; 25(1):409-19. PubMed ID: 20826539 [TBL] [Abstract][Full Text] [Related]